NEOGAP Therapeutics AB
PrivateLast Round
Early Funding
Feb 11, 2026
Est. Valuation
$23M
Total Funding Raised
$13.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NEOGAP Therapeutics AB is a biotechnology company that develops personalized cancer immunotherapy designed to precisely target and eliminate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEOGAP Therapeutics AB Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NEOGAP Therapeutics AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 11, 2026 | ||||
| Grant | Nov 5, 2025 | ||||
| Grant | Feb 26, 2025 | ||||
| Grant | Mar 26, 2024 | ||||
| Grant | Nov 9, 2023 | ||||
VC Round | Nov 9, 2023 |
Key People
Founding team and executive leadership
NEOGAP Therapeutics AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Eurostars SME programme | Grant |
| Vinnova | Grant |
| Sciety | VC Round, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2026
Raised $9.8M in early funding.
- Feb 11, 2026
Partnered with NorthX Biologics to advance cell therapy manufacturing.
NEOGAP Therapeutics AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NEOGAP Therapeutics AB's valuation, stock price, and market status.